Gladstone launches 2 new institutes — one focused on Covid-19, the other on cell therapies

The Gladstone Institutes is launching two new research units, one focused on Covid-19 and the other targeting genomics and immunology to develop next-generation cell therapies. The Gladstone Institute of Virology will be led by Dr. Melanie Ott, who has been at the center of Gladstone's work on Covid-19. This institute will zero in on Covid-19 and new therapies against future infectious diseases. Dr. Alexander Marson will lead the Gladstone-UCSF Institute of Genomic Immunology, the first institute…

Click to view original post